Litcius/Paper detail

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

Seung Hun Lee, Young‐Hoon Jeong, David Hong, Ki Hong Choi, Joo Myung Lee, Taek Kyu Park, Jeong Hoon Yang, Joo‐Yong Hahn, Seung‐Hyuck Choi, Hyeon‐Cheol Gwon, Myung Ho Jeong, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Yongwhi Park, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae‐Young Her, Hyo-Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Young Bin Song

2023JACC: Cardiovascular Interventions40 citationsDOIOpen Access PDF

Topics & Concepts

ClopidogrelCYP2C19Percutaneous coronary interventionMedicineInternal medicineConventional PCIAcute coronary syndromeGenotypingCardiologyMyocardial infarctionGenotypeGeneCytochrome P450ChemistryBiochemistryMetabolismAntiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and TreatmentsAcute Myocardial Infarction Research
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention | Litcius